Plavix's Day In Supreme Court: Is California Playing Fair On Product Liability?
Executive Summary
In Bristol case with significant implications for venue shopping, justices question whether courts can preside over suits brought by out-of-state plaintiffs against out-of-state defendants.
You may also be interested in...
Liability Win For Industry As US Supreme Court Curtails Forum-Shopping
State courts cannot exercise specific jurisdiction over personal injury claims brought by out-of-state residents, high court says in favorable decision for Plavix marketer Bristol-Myers Squibb. Ruling likely to result in smaller mass tort lawsuits, but more of them across the country.
Biopharma Patent Disputes: Upheaval Likely As US Supreme Court Limits Litigation Venue
Decision requiring suits to be filed in state where defendant is incorporated may deter consolidation of ANDA suits and increase venue fights; Court to hear challenge to PTAB inter partes review process.
RSV Vaccine May Be On Market In 2023, CDC’s ACIP Anticipates
Panel expects to review five respiratory syncytial virus vaccines and vote on one or two of them in June 2023 and others four months later. Sanofi presents results of three clinical trials of its monoclonal antibody nirsevimab, which is on track to be the second RSV prophylaxis for infants.